Literature DB >> 26523380

Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia.

Yuki Aoki1, Reiji Miyawaki, Kohsuke Imai, Masatoshi Takagi, Michiko Kajiwara, Yasuyoshi Ishiwata, Masato Yasuhara, Tomohiro Morio, Shuki Mizutani, Daisuke Tomizawa.   

Abstract

Outcome of children with acute lymphoblastic leukemia (ALL) has improved over the years, but not for those with multiple recurrences because of high therapy resistance and heavily pretreated history that potentially cause physical damages. We describe the case of an 11-year-old boy with a third relapse of ALL and a history of 2 allogeneic bone marrow transplantations. He was successfully treated with clofarabine combination chemotherapy and achieved a fourth remission at 16 months following haploidentical bone marrow transplantation with conditioning regimen of clofarabine and busulfan. Clofarabine/busulfan conditioning might be a preferable option for children with multiple recurrent ALL, and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26523380     DOI: 10.1097/MPH.0000000000000454

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.

Authors:  Masatoshi Takagi; Yasuyoshi Ishiwata; Yuki Aoki; Satoshi Miyamoto; Akihiro Hoshino; Kazuaki Matsumoto; Akira Nishimura; Mari Tanaka; Masakatsu Yanagimachi; Noriko Mitsuiki; Kohsuke Imai; Hirokazu Kanegane; Michiko Kajiwara; Kanako Takikawa; Tsukasa Mae; Osamu Tomita; Junya Fujimura; Masato Yasuhara; Daisuke Tomizawa; Shuki Mizutani; Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-02-09       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.